Sanofi has announced that it will lower the list price of its insulin drug, Lantus, by 78 percent and will set a $35 cap on out-of-pocket costs for all patients.
The price change and cap will go into effect starting January 1, 2024. They follow a series of moves made last year to lower the price of diabetes medicine, including the launch of an unbranded version of Lantus and a $35 cap for uninsured patients.
Yet, Olivier Bogillot, head of U.S. general medicines at Sanofi, said "the health system was unable to take advantage of it due to its inherent structural challenges."
“Sanofi believes that no one should struggle to pay for their insulin and we are proud of our continued actions to improve access and affordability for millions of patients for many years," he said. "Our decision to cut the list price of our lead insulin needs to be coupled with broader change to the overall system to actually drive savings for patients at the pharmacy counter.”
Sanofi will also cut the price of short-acting Apidra by 70 percent.
Wells Fargo said it could face nearly $1 billion in severance costs in the fourth quarter.
The Supreme Court on Tuesday dismissed a case surrounding a Maine hotel that could have made it harder for people with disabilities to learn in advance whether a hotel's accommodations meet their needs.
The highly-anticipated trailer for Grand Theft Auto VI is out earlier than expected.
AT&T announced a new partnership with Swedish communications company Ericsson.
Hackers accessed the personal data of 6.9 million users via the genetic testing company 23andMe.
Stocks fell after the opening bell on Tuesday morning as signs pointed to another losing session.
Bitcoin is once again having a moment. On Monday, the world's largest cryptocurrency soared past $41,000 for the first time in over a year and a half — and marking a 150% rise so far this year.
Tree farmers are raising prices for Christmas trees.
Analysis shows smaller businesses are hiring more people.
Applying for financial aid for college is a long process but there's a new streamlined application for federal student aid. Mark Kantrowitz, student loan expert, joined Cheddar News to explain the FAFSA form and what kind of changes are expected.
